Pershing Square to Invest $900 million to Acquire Nine Million Newly Issued Shares of Howard Hughes Holdings and Transform HHH Into a Diversified Holding Company
Pershing Square to Support HHH’s Strategic Expansion Through Investment, Advisory, and Other Resources HHH Will Operate as a Diversified Holding Company Seeking to Acquire Controlling Interests in High-Quality, Durable Growth…
SHARC Energy Announces Board of Director Changes
VANCOUVER, British Columbia, May 05, 2025 (GLOBE NEWSWIRE) -- SHARC International Systems Inc. (CSE: SHRC) (FSE: IWIA) (OTCQB: INTWF) ("SHARC Energy" or the “Company”) is pleased to announce that Fred…
Watsco Acquires Southern Ice Equipment Distributors
MIAMI, May 05, 2025 (GLOBE NEWSWIRE) -- Watsco, Inc. (NYSE: WSO) announced that it has completed the acquisition of Southern Ice Equipment Distributors as well as two other transactions completed…
Werewolf Therapeutics to Participate in Upcoming Investor Conferences
WATERTOWN, Mass., May 05, 2025 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to…
Vencora Expands Presence in Australia with Acquisition of Data Action
TORONTO, May 05, 2025 (GLOBE NEWSWIRE) -- Vencora, a long-term acquirer of financial services technology companies, today announced that it has acquired Data Action (“DA”), a leading Australian provider of…
Hydreight Technologies Appoints Dr. Roebuck As a Director of the Company
VANCOUVER, British Columbia, May 05, 2025 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (TSXV: NURS) (OTCQB: HYDTF) (FSE: SO6) ("Hydreight" or the "Company"), a North American, fully integrated, mobile clinical network…
Firefly Neuroscience Achieves Multi-Fold Database, IP Portfolio, and Commercial Footprint Expansion Through Acquisition of Evoke Neuroscience, Inc.
Builds upon Firefly’s recent acceptance into the NVIDIA Connect program Marks next major step toward building a proprietary foundation model of the human brain KENMORE, N.Y., May 05, 2025 (GLOBE…
Werewolf Therapeutics Presents New Preclinical Data Further Characterizing its IL-10 INDUKINE Molecule, WTX-921, for the Treatment of Inflammatory Bowel Disease (IBD) at AAI Annual Meeting
- Data reveal WTX-921 is efficacious in a mouse colitis model, resulting in reduced tissue damage and inflammatory cytokine production - - Findings offer a more detailed understanding of WTX-921’s…
MARA Announces Bitcoin Production and Mining Operation Updates for April 2025
Energized Hash Rate Grew 5.5% to 57.3 EH/sIncreased BTC Holdings* to 48,237 BTC Fort Lauderdale, FL, May 05, 2025 (GLOBE NEWSWIRE) -- MARA Holdings, Inc. (NASDAQ: MARA) ("MARA" or the…
Aspo to publish its Interim Report for January-March 2025 on May 12, 2025
Aspo Plc Press Release May 5, 2025 at 3.15 p.m. Aspo to publish its Interim Report for January-March 2025 on May 12, 2025Aspo Plc will publish Interim Report for January-March…